Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base
2015 · Journal of Clinical Oncology · 111 citations
https://doi.org/10.1200/jco.2015.63.7801
D
Donald R. Lannin
Yale University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
196
Papers
6.8K
Citations
39
h-index
79
i10-index
Donald R. Lannin is an academic researcher from Yale University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Global Cancer Incidence and Screening. The author has an h-index of 39, co-authored 167 publications.
ORCID: 0000-0001-8700-7675Papers by this author
worksQuantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer
2013 · Laboratory Investigation · 99 citations
https://doi.org/10.1038/labinvest.2013.128
Characteristics of Multifocal and Multicentric Breast Cancers
2015 · Annals of Surgical Oncology · 43 citations
https://doi.org/10.1245/s10434-015-4430-6
Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer
2017 · Annals of Surgical Oncology · 41 citations
https://doi.org/10.1245/s10434-017-5936-x
Brief‐exposure to preoperative bevacizumab reveals a TGF‐β signature predictive of response in HER2‐negative breast cancers
2015 · International Journal of Cancer · 18 citations
https://doi.org/10.1002/ijc.29808
Racial Differences in Utilization of Breast Conservation Surgery: Results from the National Cancer Data Base (NCDB)
2016 · Annals of Surgical Oncology · 18 citations
https://doi.org/10.1245/s10434-016-5475-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat